Th22 cells promote osteoclast differentiation while neutralization of IL-22 inhibits osteoclast formation, suggesting that blocking IL-22 could be effective in suppressing bone destruction in RA patients (98). The gene discussed is IL22; the disease is rheumatoid arthritis.